Hope on the Horizon: Innovations in Tourette Syndrome Care

This session will provide a comprehensive overview of the latest developments in the treatment of Tourette Syndrome and other tic disorders. Attendees will gain insight into emerging pharmacological options, including promising updates on ecopipam and gemlapodect. The presentation will also explore relevant updates on non-pharmacological tic-targeting treatments, including nutraceuticals, advancements in behavioral therapy techniques, and the potential role for non-invasive brain stimulation methods.

Due to the clinical content and nature of the research being discussed, this session is limited to licensed medical professionals and providers. Some of the findings presented have not yet been made available for public release. Therefore, pre-registration is required and must include verification of your NPI number and/or professional licensure.

If you are unable to provide your NPI number, please email a copy of your medical licensure to resmed@tourette.org.